Terms: = Kidney tumors AND TFEB, TCFEB, 7942, ENSG00000112561, P19484, AlphaTFEB AND Treatment
24 results:
1. Prognosis and Clinicopathological Characters of Adult tfeb-Altered Renal Cell Carcinoma: A Single Center Experience of 18 Cases.
Wu J; Cao CZ; Cui HL; Du G; Shi HZ; Liang J; Guo L; Wang YC; Zhang J; Zhou AP; Li CL; Zheng S; Shou JZ
Clin Genitourin Cancer; 2024 Apr; 22(2):261-268.e3. PubMed ID: 38104031
[TBL] [Abstract] [Full Text] [Related]
2. Genomic alterations and diagnosis of renal cancer.
Zhang X; Bolck HA; Rupp NJ; Moch H
Virchows Arch; 2024 Feb; 484(2):323-337. PubMed ID: 37999735
[TBL] [Abstract] [Full Text] [Related]
3. A
Smith SC; Yu J; Paul AK
Int J Surg Pathol; 2024 May; 32(3):539-542. PubMed ID: 37415407
[TBL] [Abstract] [Full Text] [Related]
4. Metastatic Translocated Renal Cell Carcinoma in a kidney Transplant Patient - a Case Report and Review of the Literature.
Kläger J; Schmidinger M; Oszwald A; Wasinger G; Fajkovic H; Compérat E
Int J Surg Pathol; 2024 May; 32(3):594-600. PubMed ID: 37415400
[No Abstract] [Full Text] [Related]
5. Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells.
Shirono Y; Bilim V; Anraku T; Kuroki H; Kazama A; Murata M; Hiruma K; Tomita Y
Curr Oncol; 2023 May; 30(6):5350-5365. PubMed ID: 37366889
[TBL] [Abstract] [Full Text] [Related]
6. High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma.
Lang M; Schmidt LS; Wilson KM; Ricketts CJ; Sourbier C; Vocke CD; Wei D; Crooks DR; Yang Y; Gibbs BK; Zhang X; Klumpp-Thomas C; Chen L; Guha R; Ferrer M; McKnight C; Itkin Z; Wangsa D; Wangsa D; James A; Difilippantonio S; Karim B; Morís F; Ried T; Merino MJ; Srinivasan R; Thomas CJ; Linehan WM
J Exp Clin Cancer Res; 2023 Apr; 42(1):99. PubMed ID: 37095531
[TBL] [Abstract] [Full Text] [Related]
7. MiT/TFE Family Renal Cell Carcinoma.
Tang J; Baba M
Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672892
[TBL] [Abstract] [Full Text] [Related]
8. tfeb-associated renal cell carcinoma: A case report and literature review.
Zhu Y; Xia C; Ou Y; Zhang C; Li L; Yang D
Medicine (Baltimore); 2022 Dec; 101(50):e31870. PubMed ID: 36550835
[TBL] [Abstract] [Full Text] [Related]
9. Changes in expression of lysosomal membrane proteins in leucocytes of cancer patients treated with tyrosine kinase inhibitors.
Pastvova N; Havlasek J; Dolezel P; Kikalova K; Studentova H; Zemankova A; Melichar B; Mlejnek P
Cancer Chemother Pharmacol; 2021 Jul; 88(1):89-98. PubMed ID: 33783548
[TBL] [Abstract] [Full Text] [Related]
10. [Clinicopathological analysis of clear cell renal cell carcinoma with hemangioblastoma component].
Huang HJ; Chen MJ; Li XO; Zhong DR
Zhonghua Bing Li Xue Za Zhi; 2021 Feb; 50(2):103-107. PubMed ID: 33535303
[No Abstract] [Full Text] [Related]
11. Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (SIOP) 93-01, 2001 and UK-IMPORT database: A report of the SIOP-Renal Tumor Study Group.
van der Beek JN; Hol JA; Coulomb-l'Hermine A; Graf N; van Tinteren H; Pritchard-Jones K; Houwing ME; de Krijger RR; Vujanic GM; Dzhuma K; Schenk JP; Littooij AS; Ramírez-Villar GL; Murphy D; Ray S; Al-Saadi R; Gessler M; Godzinski J; Ruebe C; Collini P; Verschuur AC; Frisk T; Vokuhl C; Hulsbergen-van de Kaa CA; de Camargo B; Sandstedt B; Selle B; Tytgat GAM; van den Heuvel-Eibrink MM
Int J Cancer; 2021 Jun; 148(11):2724-2735. PubMed ID: 33460450
[TBL] [Abstract] [Full Text] [Related]
12. TFE3-PD-L1 axis is pivotal for sunitinib resistance in clear cell renal cell carcinoma.
Guo X; Li R; Bai Q; Jiang S; Wang H
J Cell Mol Med; 2020 Dec; 24(24):14441-14452. PubMed ID: 33145941
[TBL] [Abstract] [Full Text] [Related]
13. Primary retroperitoneal renal cell carcinoma associated with transcription EB gene fusion.
Liu Z; Hua X
Minerva Med; 2024 Feb; 115(1):32-36. PubMed ID: 32239878
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets.
Caliò A; Brunelli M; Segala D; Pedron S; Remo A; Ammendola S; Munari E; Pierconti F; Mosca A; Bollito E; Sidoni A; Fisogni S; Sacco C; Canu L; Sentinelli S; Fraccon AP; Fiorentino M; Scott C; Milella M; Porta C; Argani P; Martignoni G
Pathology; 2020 Apr; 52(3):297-309. PubMed ID: 32107074
[TBL] [Abstract] [Full Text] [Related]
15. [MiT family translocation renal cell carcinomas: Natural history, molecular features and multidisciplinary management].
Herrscher H; Boilève A; Lindner V; Barthélémy P; Hutt É; Pierard L; Kurtz JE; Rioux-Leclercq N; Lang H; Malouf GG
Bull Cancer; 2020 Feb; 107(2):272-280. PubMed ID: 32044098
[TBL] [Abstract] [Full Text] [Related]
16. tfeb Mediates Immune Evasion and Resistance to mTOR Inhibition of Renal Cell Carcinoma via Induction of PD-L1.
Zhang C; Duan Y; Xia M; Dong Y; Chen Y; Zheng L; Chai S; Zhang Q; Wei Z; Liu N; Wang J; Sun C; Tang Z; Cheng X; Wu J; Wang G; Zheng F; Laurence A; Li B; Yang XP
Clin Cancer Res; 2019 Nov; 25(22):6827-6838. PubMed ID: 31383732
[TBL] [Abstract] [Full Text] [Related]
17. Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders.
Boilève A; Carlo MI; Barthélémy P; Oudard S; Borchiellini D; Voss MH; George S; Chevreau C; Landman-Parker J; Tabone MD; Chism DD; Amin A; Bilen MA; Bosse D; Coulomb-L'hermine A; Su X; Choueiri TK; Tannir NM; Malouf GG
J Immunother Cancer; 2018 Dec; 6(1):159. PubMed ID: 30591082
[TBL] [Abstract] [Full Text] [Related]
18. Clinical Utility of Chromosome Genomic Array Testing for Unclassified and Advanced-Stage Renal Cell Carcinomas.
Andeen NK; Qu X; Antic T; Tykodi SS; Fang M; Tretiakova MS
Arch Pathol Lab Med; 2019 Apr; 143(4):494-504. PubMed ID: 30383394
[TBL] [Abstract] [Full Text] [Related]
19. Xp11 Translocation Renal Cell Carcinoma and the Mesenchymal Counterparts: An Evolving Concept with Novel Insights on Clinicopathologic Features, Prognosis, treatment, and Classification.
Wang XT; Xia QY; Zhou XJ; Rao Q
Crit Rev Oncog; 2017; 22(5-6):481-497. PubMed ID: 29604926
[TBL] [Abstract] [Full Text] [Related]
20. Translocational renal cell carcinoma (t(6;11)(p21;q12) with transcription factor EB (tfeb) amplification and an integrated precision approach: a case report.
Lilleby W; Vlatkovic L; Meza-Zepeda LA; Revheim ME; Hovig E
J Med Case Rep; 2015 Dec; 9():281. PubMed ID: 26654961
[TBL] [Abstract] [Full Text] [Related]
[Next]
